Latest Burkitt's lymphoma Stories
Burkitt's lymphoma is one of the most aggressive tumors affecting humans.
Important advances in the fight against cancer have come as researchers proved that viruses and cancers interact in ways that were previously unknown to scientists.
Gene enhancer is responsible for activating cancer-causing genes in B cells.
Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue.
La Jolla Institute for Allergy & Immunology researchers studying an enzyme believed to play a role in allergy onset, instead have discovered its previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma and leukemia.
Research led by Ashok Aiyar, PhD, Associate Professor of Microbiology at LSU Health Sciences Center New Orleans, showing that a single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, will be published in the June 12, 2009 online issue of PLoS Pathogens.
Episodic adventure series results from a life of creative writings and author's battle with Burkitt's Lymphoma HUBER HEIGHTS, Ohio, March 16 /PRNewswire/ -- Randy Patterson has spent the last three years of his life fighting a deadly, aggressive and extremely rare cancer called Burkitt's Lymphoma.
ORLANDO, Fla., Dec. 9 /PRNewswire/ -- Chemotherapy, the most common type of treatment for cancer patients, can cause troublesome side effects, such as nausea and vomiting, hair loss, fatigue, and life-threatening toxicities.
Partnerships between institutions from developed and underdeveloped countries could improve treatment of children with cancer even in areas of the world that have limited resources, according to St. Jude.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.